(19)
(11) EP 1 631 289 A2

(12)

(88) Date of publication A3:
29.12.2005

(43) Date of publication:
08.03.2006 Bulletin 2006/10

(21) Application number: 04752748.6

(22) Date of filing: 20.05.2004
(51) International Patent Classification (IPC): 
A61K 31/497(2000.01)
 A61K 31/33(1985.01)
(86) International application number:
PCT/US2004/015791
(87) International publication number:
WO 2004/108076 (16.12.2004 Gazette 2004/51)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 02.06.2003 US 474964 P
04.06.2003 US 475642 P
01.08.2003 US 478648 P
22.04.2004 US 564636 P

(71) Applicants:
  • Samaritan Pharmaceuticals, Inc.
    Las Vegas, NV 89109 (US)
  • GEORGETOWN UNIVERSITY
    Washington, DC 20057 (US)
  • Papadopoulos, Vassilios
    North Potomac, MD 20878 (US)
  • Greeson, Janet
    Las Vegas, NV 89109 (US)
  • Lecanu, Laurent
    McLean, VA 22102 (US)

(72) Inventors:
  • PAPADOPOULOS, Vassilios
    North Potomac, MD 20878 (US)
  • GREESON, Janet
    Las Vegas, NV 89109 (US)
  • LECANU, Laurent
    McLean, VA 22102 (US)

(74) Representative: Lucas, Phillip Brian et al
Lucas & Co. 135 Westhall Road
GB-Warlingham, Surrey CR6 9HJ
GB-Warlingham, Surrey CR6 9HJ (GB)

   


(54) ANTI-HIV BENZAMIDE COMPOUNDS